Evidence of High Out of Pocket Spending for HIV Care Leading to Catastrophic Expenditure for Affected Patients in Lao People's Democratic Republic

Hubert Barennes, Amphonexay Frichittavong, Marissa Gripenberg, Paulin Koffi, Hubert Barennes, Amphonexay Frichittavong, Marissa Gripenberg, Paulin Koffi

Abstract

Background: The scaling up of antiviral treatment (ART) coverage in the past decade has increased access to care for numerous people living with HIV/AIDS (PLWHA) in low-resource settings. Out-of-pocket payments (OOPs) represent a barrier for healthcare access, adherence and ART effectiveness, and can be economically catastrophic for PLWHA and their family. We evaluated OOPs of PLWHA attending outpatient and inpatient care units and estimated the financial burden for their households in the Lao People's Democratic Republic. We assumed that such OOPs may result in catastrophic health expenses in this context with fragile economical balance and low health insurance coverage.

Methods: We conducted a cross-sectional survey of a randomized sample of routine outpatients and a prospective survey of consecutive new inpatients at two referral hospitals (Setthathirat in the capital city, Savannaket in the province). After obtaining informed consent, PLWHA were interviewed using a standardized 82-item questionnaire including information on socio-economic characteristics, disease history and coping strategies. All OOPs occurring during a routine visit or a hospital stay were recorded. Household capacity-to-pay (overall income minus essential expenses), direct and indirect OOPs, OOPs per outpatient visit and per inpatient stay as well as catastrophic spending (greater than or equal to 40% of the capacity-to-pay) were calculated. A multivariate analysis of factors associated with catastrophic spending was conducted.

Results: A total of 320 PLWHA [280 inpatients and 40 outpatients; 132 (41.2%) defined as poor, and 269 (84.1%) on ART] were enrolled. Monthly median household income, essential expenses and capacity-to-pay were US$147.0 (IQR: 86-242), $126 (IQR: 82-192) and $14 (IQR: 19-80), respectively. At the provincial hospital OOPs were higher during routine visits, but three fold lower during hospitalization than in the central hospital ($21.0 versus $18.5 and $110.8 versus $329.8 respectively (p<0.01). The most notable OOPs were related to transportation and to loss of income. A total of 150 patients (46.8%; 95%CI: 41.3-52.5) were affected by catastrophic health expenses; 36 outpatients (90.0%; 95%CI: 76.3-97.2) and 114 inpatients (40.7%; 95%CI: 34.9-46.7). A total of 141 (44.0%) patients had contracted loans, and 127 (39.6%) had to sell some of their assets. In the multivariate analysis, being of Lao Loum ethnic group (Coef.-1.4; p = 0.04); being poor (Coef. -1.0; p = 0.01) and living more than 100 km away from the hospital (Coef.-1.0; p = 0.002) were positively associated with catastrophic spending. Conversely being in the highest wealth quartile (Coef. 1.6; p<0.001), living alone (Coef. 1.1; p = 0.04), attending the provincial hospital (Coef. 1.0; p = 0.002), and being on ART (Coef.1.2; p = 0.003), were negatively associated with catastrophic spending.

Conclusion: PLWHA's households face catastrophic OOPs that are not directly attributable to the cost of ART or to follow-up tests, particularly during a hospitalization period. Transportation, distance to healthcare and time spent at the health facility are the major contributors for OOPs and for indirect opportunity costs. Being on ART and attending the provincial hospital were associated with a lower risk of catastrophic spending. Decentralization of care, access to ART and alleviation of OOPs are crucial factors to successfully decrease the household burden of HIV-AIDS expenses.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Flow chart of the study…
Fig 1. Flow chart of the study population.

References

    1. Tran BX, Duong AT, Nguyen LT, Hwang J, Nguyen BT, Nguyen QT, et al. (2013) Financial burden of health care for HIV/AIDS patients in Vietnam. Tropical Medicine & International Health 18: 212–218.
    1. Rajagopalan N, Suchitra JB, Shet A, Khan ZK, Martin-Garcia J, Nonnemacher MR, et al. (2009) Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatients at a Community Care Center. Am J Infect Dis 5: 219–224.
    1. Bikilla AD, Jerene D, Robberstad B, Lindtjorn B (2009) Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia. Cost Eff Resour Alloc 7: 6 1478-7547-7-6 [pii]; 10.1186/1478-7547-7-6
    1. Araujo DV, Bahia L, Stella SF (2013) The Economic Burden of HIV/AIDS and myocardial infarction treatment in Brazil. ScientificWorldJournal 2013: 864962 10.1155/2013/864962
    1. Kitajima T, Kobayashi Y, Chaipah W, Sato H, Chadbunchachai W, Thuennadee R (2003) Costs of medical services for patients with HIV/AIDS in Khon Kaen, Thailand. AIDS 17: 2375–2381. 10.1097/01.aids.0000096859.36052.8e
    1. Angeletti C, Pezzotti P, Antinori A, Mammone A, Navarra A, Orchi N, et al. (2014) Antiretroviral treatment-based cost saving interventions may offset expenses for new patients and earlier treatment start. HIV Med 15: 165–174. 10.1111/hiv.12097
    1. Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, et al. (2006) Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis 42: 1003–1010. CID37072 [pii]; 10.1086/500453
    1. Kouanda S, Bocoum FY, Doulougou B, Bila B, Yameogo M, Sanou MJ, et al. (2010) User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country. AIDS Care 22: 1146–1152. 926639475 [pii]; 10.1080/09540121003605047
    1. Boufkhed S, Taverne B (2014) Assessing the direct cost of medical care for HIV between the third and tenth year of ARV treatment in Dakar. Bull Soc Pathol Exot 107: 292–298. 10.1007/s13149-014-0374-5
    1. Anh DT, Kato M, Bales S, Nhan DT, Thu NTM, Thuy CTT, et al. (2014) Costing analysis of national HIV treatment and care program in Vietnam. J Acquir Immune Defic Syndr.
    1. Broughton E, Nunez D, Moreno I (2014) Cost-Effectiveness of Improving Health Care to People with HIV in Nicaragua. Nurs Res Pract 2014: 232046 10.1155/2014/232046
    1. Nguyen LT, Tran BX, Tran CT, Le HT, Tran SV (2014) The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam . Clinicoecon Outcomes Res 6: 101–108. 10.2147/CEOR.S57028 ceor-6-101 [pii].
    1. Beauliere A, Toure S, Alexandre PK, Kone K, Pouhe A, Kouadio B, et al. (2010) The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Cote d'Ivoire. PLoS One 5: e11213 10.1371/journal.pone.0011213
    1. Duraisamy P, Ganesh AK, Homan R, Kumarasamy N, Castle C, Sripriya P, et al. (2006) Costs and financial burden of care and support services to PLHA and households in South India . AIDS Care 18: 121–127. VV085246H30446U5 [pii]; 10.1080/09540120500159359
    1. Moon S, Van LL, Durier N, Jambert E, Dahmane A, Jie Y, et al. (2008) Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough? AIDS Care 20: 984–994. 902175225 [pii]; 10.1080/09540120701768446
    1. Posse M, Baltussen R (2009) Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS 23: 867–875. 10.1089/apc.2009.0050
    1. Zachariah R, Van EI, Massaquoi M, Kocholla L, Manzi M, Suleh A, et al. (2008) Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Trans R Soc Trop Med Hyg 102: 288–293. S0035-9203(07)00439-7 [pii]; 10.1016/j.trstmh.2007.12.007
    1. Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, et al. (2009) Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ 87: 279–287. S0042-96862009000400013 [pii].
    1. Posse M, Meheus F, van Austen H, van der Ven A, Baltussen R (2008) Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health 13: 904–913. TMI2091 [pii]; 10.1111/j.1365-3156.2008.02091.x
    1. Richter LM, Lonnroth K, Desmond C, Jackson R, Jaramillo E, Weil D (2014) Economic support to patients in HIV and TB grants in rounds 7 and 10 from the global fund to fight AIDS, tuberculosis and malaria. PLoS One 9: e86225 10.1371/journal.pone.0086225 PONE-D-13-25774 [pii].
    1. Pannarunothai S, Mills A (1997) The poor pay more: health-related inequality in Thailand. Soc Sci Med 44: 1781–1790. S0277953696002870 [pii].
    1. Lopera MM, Einarson TR, Ivan BJ (2011) Out-of-pocket expenditures and coping strategies for people living with HIV: Bogota, Colombia, 2009. AIDS Care 23: 1602–1608. 10.1080/09540121.2011.579938
    1. Bila B, Kouanda S, Desclaux A (2008) [From economic difficulties to social suffering of people living with HIV in Burkina Faso]. Sante 18: 187–191.
    1. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ (2003) Household catastrophic health expenditure: a multicountry analysis. The Lancet 362: 111–117. S0140-6736(03)13861-5 [pii]; 10.1016/S0140-6736(03)13861-5
    1. Barennes H, Tat S, Reinharz D, Vibol U (2014) Perceived stigma by children on antiretroviral treatment in Cambodia. BMC Pediatr 14: 300 s12887-014-0300-9 [pii]; 10.1186/s12887-014-0300-9
    1. Choi JW, Choi JW, Kim JH, Yoo KB, Park EC (2015) Association between chronic disease and catastrophic health expenditure in Korea . BMC Health Serv Res 15: 26 10.1186/s12913-014-0675-1 s12913-014-0675-1 [pii].
    1. Li Y, Wu Q, Xu L, Legge D, Hao Y, Gao L (2012) Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance. Bull World Health Organ 90: 664–671. 10.2471/BLT.12.102178 BLT.12.102178 [pii].
    1. Thuan NT, Lofgren C, Chuc NT, Janlert U, Lindholm L (2006) Household out-of-pocket payments for illness: evidence from Vietnam. BMC Public Health 6: 283 1471-2458-6-283 [pii]; 10.1186/1471-2458-6-283
    1. Van DW, Van LL, Por I, Hardeman W, Meessen B (2004) Out-of-pocket health expenditure and debt in poor households: evidence from Cambodia. Trop Med Int Health 9: 273–280.
    1. Van MH, Kim Phuong NT, Saksena P, James CD, Xu K (2013) Financial burden of household out-of pocket health expenditure in Viet Nam: findings from the National Living Standard Survey 2002–2010. Soc Sci Med 96: 258–263. S0277-9536(12)00787-3 [pii]; 10.1016/j.socscimed.2012.11.028
    1. Ngorsuraches S, Chaiyakan K (2015) Equitable Prices of Single-Source Drugs in Thailand. Appl Health Econ Health Policy. 10.1007/s40258-015-0165-6
    1. Prakongsai P, Limwattananon S, Tangcharoensathien V (2009) The equity impact of the universal coverage policy: lessons from Thailand. Adv Health Econ Health Serv Res 21: 57–81.
    1. Yiengprugsawan V, Kelly M, Seubsman SA, Sleigh AC (2010) The first 10 years of the Universal Coverage Scheme in Thailand: review of its impact on health inequalities and lessons learnt for middle-income countries. Australas epidemiol 17: 24–26.
    1. Akkhavong K, Paphassarang C, Phoxay C, Vonglokham M, Phommavong C, Pholsena S (2014) Lao People's Democratic Republic Health System Review. 1–160.
    1. World Bank: Vientiane Office (2015) Government Expenditure on health in Lao PDR: Overall Trends and findingd from a Health center survey.
    1. The World Bank (2015) The World Bank: Lao PDR.
    1. Lao Ministry of Health (2013) Sector reform Framework Lao PDR to 2025. 2–134.
    1. Lao Ministry of Health (2015) Lao National Health Accounts Report Fiscal Year 2010–2011 and 2011–2012. 2–94.
    1. Lao Ministry of Health (2015) Draft Health Financing Strategy, Lao PDR 2014–2025. 2–55.
    1. Lao PDR Ministry of Health (2014) Key features of the official Social Health Protection schemes in Lao PDR for the year 2013. 1–11.
    1. Minh HV, Pocock NS, Hanvoravongchai P, Soe KM (2015) Progress towards Universal Health Coverage in ASEAN.
    1. World Bank (2015) Lao economic monitor: towards restoring macroeconomic stability and building inclusive growth. 1–48.
    1. UNAIDS (2013) Lao PDR country report progress. 1–127.
    1. Paboriboune P, Ngin S, Kieffer A, Phimphachanh B, Bouchard P, Fan N, et al. (2012) HIV viral load testing in Laos. Field action science reports.
    1. Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, et al. (2013) Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR . BMC Public Health 13: 617 1471-2458-13-617 [pii]; 10.1186/1471-2458-13-617
    1. Pinto AD, van LM, Rachlis B, Chan AK, Sodhi SK (2013) Patient costs associated with accessing HIV/AIDS care in Malawi. J Int AIDS Soc 16: 18055 18055 [pii]. 10.7448/IAS.16.1.18055
    1. Morineau G, Vun MC, Barennes H, Wolf RC, Song N, Prybylski D, et al. (2009) Survival and quality of life among HIV-positive people on antiretroviral therapy in Cambodia. AIDS Patient Care STDS 23: 669–677. 10.1089/apc.2008.0241
    1. Vun MC, Fujita M, Rathavy T, Eang MT, Sopheap S, Sovannarith S, et al. (2014) Achieving universal access and moving towards elimination of new HIV infections in Cambodia. J Int AIDS Soc 17: 18905 18905 [pii]. 10.7448/IAS.17.1.18905
    1. Zhou F, Kominski GF, Qian HZ, Wang J, Duan S, Guo Z, et al. (2011) Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs. BMC Med 9: 6 1741-7015-9-6 [pii]; 10.1186/1741-7015-9-6
    1. Lao Ministry of Health (2015) Lao National Health Accounts Report Fiscal Year 2010–2011 and 2011–2012. 2–94.
    1. Lao Ministry of Health (2015) Draft Health Financing Strategy, Lao PDR 2014–2025. 2–55.
    1. World Bank: Vientiane Office (2015) Government Expenditure on health in Lao PDR: Overall Trends and finding from a Health center survey. S1 Dataset-on catastrophic health spending in HIV patients in Laos

Source: PubMed

Подписаться